Cigna Expands Coverage of Glaucoma Surgical Procedures to
Cigna has close to 15 million covered lives Cigna’s Coverage Policy includes procedures enabled with OMNI® Surgical System technology as medically...
Stay updated with breaking news from Sight Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cigna has close to 15 million covered lives Cigna’s Coverage Policy includes procedures enabled with OMNI® Surgical System technology as medically...
Cigna Healthcare has updated its glaucoma surgical procedure policy to cover both ab interno canaloplasty and goniotomy to treat primary open-angle glaucoma, according to a press release from Sight Sciences.
The ophthalmic viscoelastic devices are vital for various ophthalmic surgical procedures including corneal transplantation surgery, glaucoma surgery,
Shares of Sight Sciences, Inc. (NASDAQ:SGHT – Get Rating) have been given an average rating of “Moderate Buy” by the seven research firms that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 […]
Sight Sciences (NASDAQ:SGHT – Get Rating) had its price target cut by Bank of America from $13.00 to $10.00 in a research report report published on Tuesday, The Fly reports. Sight Sciences Trading Down 1.8 % Shares of Sight Sciences stock opened at $7.81 on Tuesday. The firm has a 50-day simple moving average of […]